Medical News

RSS

MMR and Dutchess Equity Fund sign investment agreement

MMR Information Systems, Inc. (OTCBB: MMRF) (the "Company"), which, through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides consumer-controlled Personal Health Records (www.mymedicalrecords.com) and electronic safe deposit box storage solutions (www.myesafedepositbox.com), announced today that it has entered into an Investment Agreement (the "Agreement") for an $8,000,000 equity line of credit with Dutchess Equity Fund, LP ("Dutchess").

16 Sep 2009

Medicare Advantage's preventive health care strategy keeps seniors out of the hospital

Seniors in Medicare Advantage spent fewer days in a hospital, were subject to fewer hospital re-admissions, and were less likely to have "potentially avoidable" admissions, for common conditions ranging from uncontrolled diabetes to dehydration, according to a new analysis of publicly available AHRQ data released today by America's Health Insurance Plans (AHIP).

16 Sep 2009

Roche's peg-EPO product Mircera infringes Amgen patents

Amgen (Nasdaq: AMGN) today announced that the Court of Appeals for the Federal Circuit affirmed the Massachusetts District Court's decision that Roche's peg-EPO product, Mircera, infringes four Amgen patents ('868, '698, '933 and '422) relating to recombinant erythropoietin (EPO) and processes for making it.

16 Sep 2009

Health care reform should include protections for retiree health care benefits

The executive director of a national retiree advocacy group has called proposals for nationalized health care (HR 3200) a "back-door bailout" that would enable companies to skip out on fiscal obligations to retirees and stick the taxpayers with the bill.

16 Sep 2009

EVEREST clinical trial results to be presented at the upcoming TCT Conference

The upcoming Transcatheter Cardiovascular Therapeutics (TCT) Conference, to take place in San Francisco from September 21-25, will serve as a backdrop for the presentation of EVEREST registry clinical results of the MitraClip(R) therapy for patients with mitral regurgitation (MR).

16 Sep 2009

Color-coded BMI charts help easy analysis of child's weight

A new study shows that parents are more likely to understand a body mass index (BMI) chart if it's color-coded, like a traffic light, than the standard charts currently in use.

16 Sep 2009

LEAD Therapeutics' LT-29 antibiotic effective against most common antibiotic resistant bacteria

LEAD Therapeutics, a privately held drug discovery company, announced the discovery of a novel antibiotic with potent activity against many of the most common antibiotic resistant bacteria.

16 Sep 2009

Patients with celiac disease face increased risk of mortality

New research indicates that patients with lesser degrees of celiac disease-related symptoms, such as intestinal inflammation or latent celiac disease, have a modestly increased risk of death, according to a study in the September 16 issue of JAMA.

16 Sep 2009

New cancer therapy involves remodelling blood vessels and activating immune cells

Reversing or re-arranging the growth of these vessels in combination with specific immune strategies is a promising new strategy for cancer therapy, says Ruth Ganss, Professor at the Western Australian Institute for Medical Research, Perth, at the 2nd European Congress of Immunology ECI 2009 held in Berlin.

16 Sep 2009

Research study conducted to understand radiation-induced bone loss

A research project looking for ways to reduce bone loss in astronauts may yield methods of improving the bone health of cancer patients undergoing radiation treatment.

16 Sep 2009

GENova allies with academic institutions specializing in stem cell research

GENova Biotherapeutics Inc. ("GENova") today announced that it is forming strategic alliances with academic research institutions specializing in ground-breaking stem cell research.

16 Sep 2009

PhotoMedex unveils Neova DNA Repair Factor Nourishing Lotion

PhotoMedex, Inc., a leading provider of advanced dermatology, clinical skincare and medical laser products, today announced Neova DNA Repair Factor Nourishing Lotion, the newest addition to its renowned Neova brand of skin and hair products.

16 Sep 2009

Some Senate Dems voice concerns with Baucus bill

Sen. Max Baucus' pursuit of a bipartisan health care reform bill is being met with increasing skepticism from his own party.

16 Sep 2009

Sparton Corporation reports fiscal year end 2009 results

Sparton Corporation (NYSE: SPA) today announced results for the fiscal year ended June 30, 2009.

16 Sep 2009

Acute kidney injury multiplies the risk of future kidney complications

Patients who sustain injury to their kidneys and require in-hospital dialysis are three times more likely to need long-term dialysis later in life compared to those without a history of this condition, says a new study from St. Michael's Hospital.

16 Sep 2009

FDA approves sBLA for Influenza A (H1N1) 2009 Monovalent Vaccine

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental biologics license application (sBLA) for licensure of its Influenza A (H1N1) 2009 Monovalent Vaccine.

16 Sep 2009

Cancer Program established to treat young cancer patients

A new partnership of Providence Health & Services, Childrens Hospital Los Angeles and the Childrens Hospital Los Angeles Medical Group has been developed to treat young adults with cancer, providing diagnostics and treatment for a group that nationwide falls in a gap between adult and pediatric health care.

16 Sep 2009

Public option politically charged on both sides of aisle

Alternatives to the government-run public option for health insurance are part of a long list of policy and politics considerations that officials are pondering in the run down to the final health care reform bill this week.

16 Sep 2009

DPM opens new thermal transfer ribbon slitting facility in New Jersey

Digital Printing Media (DPM), a member of Korim Co. Ltd., announces the recent opening of a new state-of-the-art thermal transfer ribbon slitting facility in West Caldwell, NJ.

16 Sep 2009

Optimer's North American phase 3 Fidaxomicin study results presented at the 49th ICAAC

Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR) today announced that new data highlighting fidaxomicin's (OPT-80) lower CDI recurrence rates and reduced risk of vancomycin-resistant enterococci (VRE) acquisition from Optimer's North American phase 3 study were presented at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco.

16 Sep 2009